New heart valve repair device aims to help high-risk patients avoid surgery
NCT ID NCT07243197
First seen Nov 21, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tests a new version of the DragonFly M2 device to repair leaky mitral valves in people with severe symptoms who are too high-risk for surgery. About 53 participants will get the device through a tube inserted in a vein. The goal is to see if the device safely reduces the leak and improves heart function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL VALVE (MV) REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital Chinese Academy of Medical Sciences
Shenzhen, Guangdong, 518000, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.